This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,346.55 and a period of performance through July 28, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $15,346.55 and a completion date of June 27, 2025. It is a firm fixed-price contract and is not set-aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract is a firm fixed-price delivery order with a ceiling value of $15,346.55 and a performance period through March 5, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a...
This is a $15,346.55 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABOMETYX 40 MG TABLET 30S medication, with a performance period through July 15, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 MG TABLET 30S. The contract has a firm fixed price of $15,346.55 and a period of performance through June 20, 2025. Amerisourcebergen Drug Corp is the prime contractor and holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $30,693.10, is for the delivery of 4,567,984,745 units of the medication CABOMETYX 40 MG TABLET 30S. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Cabometyx 60 mg tablets. The contract has a ceiling value of $30,602.10 and a period of performance through May 29, 2025. It is a firm fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $13,908.27 firm-fixed-price contract is for the supply of CABOMETYX 60 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of November 13, 2024 and was awarded on October 22, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CABOMETYX 60 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $15,301.05 and a completion date of July 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABOMETYX 40 mg tablets. The contract has a ceiling value of $41,601.54 and is a firm fixed-price delivery order that will be completed by August 16, 2024. The contract is not designated as a set-aside award. AmerisourceBergen, through its Corporate Office division, provides a wide range of pharmaceutical products and medical...